HOME >> MEDICINE >> NEWS
Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone

Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6% compared with surgery alone.

This conclusion was drawn by a team of Cochrane Researchers from the MRC Clinical Trials Unit in London after they identified 12 eligible randomised controlled trials. Data from seven of these trials were available from trial reports and were combined in a meta-analysis. The seven trials involved a total of 988 patients.

This is currently the best estimate of the effectiveness of this therapy, but is based on a relatively small number of trials and patients, says lead researcher Sarah Burdett.

There was, however, insufficient data to break the patients down into sub-groups and see whether the effectiveness varies for different types of patients or stages of the disease.

This research is important because around the world more than a million new cases of lung cancer are diagnosed each year, around 80% of which are non-small cell lung cancer. In addition, many patients are only diagnosed after the disease has progressed, so survival rates across all stages of disease tend to be fairly low at around 14%, with only a quarter of patients being suitable for surgery.

The Cochrane Systematic Review found that using chemotherapy before surgery can reduce the size of tumours making the surgery simpler, and increasing the number of patients who may be candidates for surgery. The worry is, however, that having a course of chemotherapy delays the operation, and could therefore leave patients at risk of allowing the tumour to spread.

The data suggest that the benefits of the chemotherapy outweigh the risks associated with the delay, says Burdett

A project to collect complete data on all patients included in all trials is ongoing and will be able to fully assess the value of this treatment.


'"/>

Contact: Jennifer Beal
jbeal@wiley.co.uk
44-012-437-70633
John Wiley & Sons, Inc.
17-Jul-2007


Page: 1

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. Stomach cancer rate set to fall further 25 percent over next decade
4. MRI finds breast cancer before it becomes dangerous
5. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
6. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
7. Pathway links inflammation, angiogenesis and breast cancer
8. Using MRI for diagnosis could help prevent breast cancer progression
9. Electric fields have potential as a cancer treatment
10. Shining light on pancreatic cancer
11. Method shows promise for early detection of pancreatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... AUSTIN, Texas (PRWEB) , ... August 04, 2020 ... ... and older adults living with memory impairment, has announced the Best Memory Care ... location, access to experts, facility features and amenities. , According to the ...
(Date:8/3/2020)... FORT WORTH, Texas (PRWEB) , ... August 03, ... ... biopharmaceutical company, today announced enrollment of the first patients with first-line advanced pancreatic ... the ongoing phase 1/2 1801 trial of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is ...
(Date:7/22/2020)... ... ... Whatever we call them – sunspots, age spots, liver spots, or solar ... Seelal, a Certified Registered Physician Assistant specializing in Dermatology with Advanced Dermatology PC ... us look older.” , In terms of the name, ‘sunspots’ or the medical term ...
(Date:7/22/2020)... TULSA, Okla. (PRWEB) , ... July 22, 2020 ... ... today announced the launch of its new Data Curation as a Service ... targeted use case modules focus on specific clinical data curation parameters and are ...
(Date:7/18/2020)... ... ... Nader Sanai, M.D., director of the Ivy Brain Tumor Center at Barrow Neurological Institute ... (#GBMDay) on July 22, 2020 to raise national consciousness. , Glioblastoma Awareness Day ... common and aggressive form of brain cancer. It also honors those who have been ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... July 31, 2020 , ... Psyma Group AG, ... panel and data collection provider, recently released the results of an international survey ... Germany and France. , “COVID-19 continues to have a major disruptive impact on ...
(Date:7/22/2020)... ... July 22, 2020 , ... Local animal nutrition expert, Dr. Anoosh Rakhshandeh, and ... pet food and supplies company – Pet Wants Lubbock. , Pet Wants’ specially-crafted, private-label ... vitamins and minerals for a complete and balanced diet in every bite. Pet Wants ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... company and advanced manufacturing solutions provider today announced that their CANSWAB™ nasopharyngeal swabs ... The Company has engineered a new 3D-printed swab design and has trademarked the ...
Breaking Medicine Technology:
Cached News: